mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-07 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |